Lorenzo Scardina
Overview
Explore the profile of Lorenzo Scardina including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
173
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kappos E, Haas Y, Schulz A, Peters F, Savanthrapadian S, Stoffel J, et al.
BMJ Open
. 2025 Feb;
15(2):e090662.
PMID: 39961719
Introduction: Up to one-fifth of breast cancer survivors will develop chronic breast cancer-related lymphoedema (BCRL). To date, complex physical decongestion therapy (CDT) is the gold standard of treatment. However, it...
2.
Taralli S, Orlandi A, Pafundi P, Tempesta V, Di Leone A, Pontolillo L, et al.
Radiol Med
. 2025 Feb;
130(3):422-437.
PMID: 39937369
Purpose: To investigate metabolic parameters from baseline F-FDG PET/CT as predictors of pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) and disease recurrence in locally advanced breast cancer (LABC) patients....
3.
DArchi S, Carnassale B, Sanchez A, Accetta C, Belli P, De Lauretis F, et al.
J Pers Med
. 2025 Jan;
15(1).
PMID: 39852228
B3 breast lesions, classified as lesions of uncertain malignant potential, present a significant diagnostic and therapeutic challenge due to their heterogeneous nature and variable risk of progression to malignancy. These...
4.
DArchi S, Carnassale B, Accetta C, Belli P, De Lauretis F, Di Guglielmo E, et al.
J Clin Med
. 2025 Jan;
14(1.
PMID: 39797153
: B3 breast lesions, characterized by uncertain malignant potential, pose a significant challenge for clinicians. With the increasing use of preoperative biopsies, there is a need for careful management strategies,...
5.
Barone Adesi L, Taraschi F, Macri G, Scardina L, Di Leone A, Franceschini G, et al.
J Clin Med
. 2024 Sep;
13(17).
PMID: 39274192
Breast cancer treatment increasingly incorporates immediate prepectoral prosthetic reconstruction after conservative mastectomy, including nipple-sparing (NSMs) and skin-sparing mastectomies (SSMs). Although recent data from the literature show that postmastectomy radiotherapy (PMRT)...
6.
Scardina L, Carnassale B, Di Leone A, Sanchez A, Biondi E, Moschella F, et al.
J Clin Med
. 2024 Jul;
13(13).
PMID: 38999531
: Breast cancer in young women aged < 40 years is rare and often aggressive with less favorable survival rates. The lack of systematic screening, later stage at diagnosis, and...
7.
Sanchez A, De Lauretis F, Bucaro A, Borghesan N, Pirrottina C, Franco A, et al.
J Clin Med
. 2024 Jul;
13(13).
PMID: 38999231
Oncoplastic surgery (OPS) reliability in the post-neoadjuvant chemotherapy (NACT) setting is still debated due to weak scientific evidences in such scenarios. Our analysis aims to report results obtained in a...
8.
Scardina L, Masetti R, Franceschini G
Front Oncol
. 2024 Mar;
14:1372633.
PMID: 38463227
No abstract available.
9.
Franco A, Di Leone A, Conti M, Fabi A, Carbognin L, Terribile A, et al.
J Pers Med
. 2023 Aug;
13(8).
PMID: 37623530
Introduction: The selection of surgery post-neoadjuvant chemotherapy (NACT) is difficult and based on surgeons' expertise. The aim of this study was to create a post-NEoadjuvant Score System (pNESSy) to choose...
10.
DAngelo A, Scardina L, Palma S, Cicero S, Maresca A, Caprini F, et al.
Eur Radiol
. 2023 Aug;
34(1):149-154.
PMID: 37526666
Objective: The objective of this retrospective study was to investigate the accuracy and feasibility of magnetic seed compared to skin tattoo in preoperative localization of impalpable breast lesions in terms...